Differential gene expression in lesional skin may signify immune-mediated lung parenchymal damage in patients with dermatomyositis - 14/04/23
Doi : 10.1016/j.jaad.2022.12.040
Katharina Shaw, MD a, ⁎ 
, Nicole Doudican, PhD b, Arnav Mishra, BA b, Nicholas Frazzette, MS b, Avrom S. Caplan, MD b, Alisa Femia, MD b, John Carucci, MD, PhD b
, Nicole Doudican, PhD b, Arnav Mishra, BA b, Nicholas Frazzette, MS b, Avrom S. Caplan, MD b, Alisa Femia, MD b, John Carucci, MD, PhD b a Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
b The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York
∗Correspondence and reprint requests to: Katharina Shaw, MD, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115Department of DermatologyBrigham and Women's HospitalHarvard Medical School75 Francis StBostonMA02115
Key words : biomarkers, dermatomyositis, interstitial lung disease, NanoString, translational research
| Drs Shaw and Doudican contributed equally to this work as co-first authors. |
|
| Drs Femia and Carucci contributed equally to this work as co-senior authors. |
|
| Funding sources: This study was supported by the Ronald O. Perelman Department of Dermatology through a donation from the patients of Dr Andrew G. Franks. |
|
| IRB approval status: Reviewed and approved by NYU Langone Health IRB. |
|
| Previous presentation: This manuscript has not been previously published and is not under consideration for publication elsewhere. |
|
| Patient consent: Not applicable. |
© 2023
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 88 - N° 5
P. 1201-1204 - mai 2023 Retour au numéro
Article précédent
- A systematic review of laser therapy for vulvar skin conditions
- Katherine Kim, Mansee Desai, Ashley Elsensohn, Christina N. Kraus
- Exploring the importance of inclusion criteria beyond the color of skin: Improvement in facial redness in skin of color subjects—An open-label, single center clinical study utilizing low molecular weight heparan sulfate
- Eva Simmons-O’Brien, Valerie D. Callender, Diane Orlinsky, Shahzeb Hassan, Chidubem A.V. Okeke, Angel S. Byrd
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?